Cytokeratin 18 Antikörper
Kurzübersicht für Cytokeratin 18 Antikörper (ABIN965968)
Target
Alle Cytokeratin 18 (KRT18) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Concentrated.
-
Immunogen
- PMC-42 Human Breast Carcinoma Cells
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: (Paraffin/Frozen).
Staining Procedure: When using paraffin-embedded and formalin-fixed tissues, predigestion with AutoZyme or high temperature antigenic unmasking technique is strongly recommended for consistent and reproducible results. The optimal conditions should be determined by the individual laboratory. The antibody may be used at a dilution of 1:50 to 1:100 with AutoProbe III. -
Kommentare
-
Cellular Localization: Cytoplasmic.
Recommended Positive Control: Colon Carcinoma -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.3 mg / ml.
-
Buffer
- 20 mM Tris-Borate, 150 mM Sodium Chloride, dialyzed media RPMI 1640/D-MEM containing Fetal Bovine Serum, BMC-6 Carrier Polysaccharides, Carrier Protein, pH 7.5
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
-
- Cytokeratin 18 (KRT18) (Keratin 18 (KRT18))
-
Andere Bezeichnung
- Cytokeratin18 (45kDa)
-
Hintergrund
- This antibody reacts with Cytokeratin 18 (45 kD) polypeptide and with a wide variety of simple epithelia. It does not react with stratified squamous epithelia. It reacts with epithelial tumors of the gastrointestinal tract, lung, breast, pancreas, ovary, and thyroid.
-
Gen-ID
- 3875
-
Pathways
- Apoptose, Caspase Kaskade in der Apoptose
Target
-